期刊文献+

裸鼠结肠癌肝转移模型中多韦替尼抗肿瘤作用的研究 被引量:3

Anti-tumor of the dovitinib on liver metastasis of colon cancer nude mice model
下载PDF
导出
摘要 目的建立稳定的裸鼠结肠癌肝转移模型,观察多韦替尼(TKI-258)药物的肿瘤抑制作用。方法将人结肠癌细胞株Lo Vo接种于裸鼠脾脏建立异位肝转移模型,随机分为TKI-258研究组和对照组。研究组TKI-258灌胃,对照组同一时间段用生理盐水。采用形态学和病理学方法比较TKI-258研究组与对照组间肝转移癌形成情况,并对TKI-258研究组肝转移的预防与治疗进行评价和鉴定。结果裸鼠结肠癌异位肝转移模型的成瘤率为100%。TKI-258研究组与对照组相比抑制肝转移癌的形成,肝转移评分也明显下降,差异有显著性意义(P<0.05)。TKI-258研究组的肝转移癌明显缩小,浸润深度变浅,部分有治愈瘢痕,两组差异在形态学上有显著性意义(P<0.05)。TKI-258研究组的肿瘤中央细胞坏死及细胞凋亡成片,只存留边缘部分肿瘤细胞,细胞分布不规则,两组在显微镜下观察差异有显著性意义(P<0.05)。结论异位肝转移模型适合对肝转移率和取材要求较高的实验研究。TKI-258对裸鼠肝转移癌的预防和治疗有一定的疗效,能有效抑制转移癌的形成,但有必要进行临床试验来证实其量化效果。 Objective To establish a feasible and stable liver metastasis model of human colon cancer in nude mice.Ob-serve of dovitinib (TKI-258) anti-tumor effect in liver metastasis model of human colon cancer.Methods Human colon cancer cell line LoVo were injected into spleen of nude mouse by ectopic implantation to establish the liver metastasis model of human colon cancer.The tumor-bearing nude mice were randomized into two groups, TKI-258 study group and con-trol group.TKI-258 was force-fed ( gavage) to study group and control group, evaluating tumor formation, growth effi-ciency and liver metastasis via morphological and histopathological examination.Results The tumor formation rate was 100% of liver metastasis of colon cancer in nude mice by ectopic implantation.TKI-258 group inhibited the liver metasta-sis compared with the control group with a statistically significance (P〈0.05).There were marked morphological differ-ence of liver metastasis between TKI-258 group and control group, which the liver metastasis of TKI-258 group was com-parably narrowed, infiltration depth became shallowed with some cured scars (P〈0.05).In addition, the liver metastasis of TKI-258 group was microscopically distinct from the control group, on which exhibited irregularly distributed cells in the edge of the tumor with cell necrosis and apoptosis in the center (P〈0.05).Conclusion This liver metastasis model of human colon cancer facilitates the preclinical research and assessment requiring high rates of liver metastasis and liver tumor formation.Moreover, TKI-258 group may have certain curative effects on prevention and treatment for liver metasta-sis model of human colon cancer in nude mice by ectopic implantation, and may has significant restraining effect on the tumor formation, which remains clinical trials to confirm the quantitative effects.
出处 《大连医科大学学报》 CAS 2014年第6期545-549,共5页 Journal of Dalian Medical University
关键词 裸鼠模型 结肠癌 肝转移 多韦替尼 nude mice model colon cancer liver metastasis dovitinb
  • 相关文献

参考文献11

  • 1Siegel R, Naishadham D, Jemal A. Cancer Statistics, 2013[J]. CA Cancer J Clin, 2013,63(1):11-30.
  • 2Hess KR, Varadhachary GR, Taylor SH, et al. Metastatic patterns in adenocarcinoma[J]. Cancer, 2006, 106:1624-1633.
  • 3Manfredi S, Lepage C, Hatem C, et al. Epidemiology and management of liver metastases from colorectal cancer[J]. Ann Surg, 2006, 244(2): 254-259.
  • 4Dubbelman AC, Upthagrove A, Beijnen JH,et al. Disposition and metabolism of 14C-dovitinib (TKI258), an inhibitor of FGFR and VEGFR, after oral administration in patients with advanced solid tumors[J]. Cancer Chemother Pharmacol,2012, 70(5):653-663.
  • 5Chan SL, Wong CH, Lau CP,et al.Preclinical evaluation of combined TKI-258 and RAD001 in hepatocellular carcinoma[J]. Cancer Chemother Pharmacol, 2013, 71(6): 1417-1425.
  • 6刘福全,王健,赵雪峰.裸鼠人异位移植胃癌肝转移和腹膜转移模型的实验研究[J].大连医科大学学报,2014,36(5):435-439. 被引量:10
  • 7Spano JP, Fagard R, Soria JC, et al. Epidermal growth factor receptor signaling in colorectal cancer: preclinical data and therapeutic perspectives[J]. Ann Oncol, 2005, 16(2): 189-194.
  • 8Aisu N, Yoshida Y, Ishii F, et al. A Successfully Resected Case of Recurrent Lung and Liver Metastases of Rectal Cancer Treated with XELIRI + Bevacizumab Therapy[J]. Case Rep Oncol, 2013, 6(1):143-147.
  • 9Muntané J, De la Rosa AJ, Docobo F, et al. Targeting tyrosine kinase receptors in hepatocellular carcinoma[J]. Curr Cancer Drug Targets, 2013, 13(3): 300-312.
  • 10Chen ZY, Shi M, Peng LX, et al. Dovitinib preferentially targets endothelial cells rather than cancer cells for the inhibition of hepatocellular carcinoma growth and metastasis[J]. J Transl Med, 2012,10:245.

二级参考文献8

  • 1Jemal A, Siegel R,Xu J, et al. Cancer statistics, 2010[J]. CA Cancer J Clin, 2011,61 (2) : 133 - 134.
  • 2Yashiro M, Chung YS, Inoue T, et al. Hepatocyte growthfactor ( HGF) produced by peritoneal fibroblasts may affectmesothelial cell morphology and promote peritoneal dissemi-nation [J]. Int J Cancer, 1996,67(2) : 289 - 293.
  • 3Miki Y, Fujitani K, Hirao M, et al. Significance of surgi-cal treatment of liver metastases from gastric cancer [ J ].Anticancer Res, 2012,32(2) : 665 -670.
  • 4Bozzetti F, Yu W, Baratti D, et al. Locoregional treatmentof peritoneal carcinomatosis from gastric cancer [ J ]. J SurgOncol, 2008,98: 273 -276.
  • 5Fidler IJ. Critical determinants of metastasis [ J]. CancerBiology, 2002,12: 89 -96.
  • 6Bhullar JS, Makarawo T, Subhas G, et al. A true ortho-topic gastric cancer murine model using electrocoagulation[J]. J Am Coll Surg, 2013,217 (1) :64 -70.
  • 7Ruan J,Song H,Li C, et al. DiR - labeled EmbryonicStem Cells for Targeted Imaging of in vivo Gastric CancerCells [J]. Theranostics, 2012,2(6) :618 - 628.
  • 8Wiehr S,von Ahsen 0,Rose L, et al. Preclinical evalua-tion of a novel c - Met inhibitor in a gastric cancer xeno-graft model using small animal PET[ J]. Mol Imaging Biol,2013,15(2) :203 -211.

共引文献9

同被引文献13

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部